Key facts
- This page summarizes Clark Golestani's Form 3/A - Amendment filing for Zapata Quantum, Inc. (ZPTA).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 07 May 2026, 16:45.
Clark Golestani - 01 May 2026 Form 3/A - Amendment Insider Report for Zapata Quantum, Inc. (ZPTA)
- Reporting relationship
- Director
- Issuer ticker
- ZPTA
- Reported as of
- 01 May 2026
- Net transaction value
- $0
- SEC form
- 3/A - Amendment
- Accepted by SEC
- 07 May 2026, 16:45:07 UTC
- Original report date
- 01 Apr 2024
- Prior SEC filing
- 10 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Clark Golestani
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Clark Golestani filed Form 3/A - Amendment for Zapata Quantum, Inc. (ZPTA) on 07 May 2026.
Change
- Previous filing in this sequence was filed on 10 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.
Reporting Owners (1)
CIK 0001563786
Primary reporting owner
Golestani Clark
- Relationship
- Director
- Address
- C/O ZAPATA QUANTUM, INC., 6 LIBERTY SQUARE, #2488, BOSTON
- Signature
- /s/ Clark Golestani
- Signature date
- 07 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZPTA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 32,626,288
- Date
- 01 May 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZPTA
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Comon Stock
- Underlying amount
- 34,279
- Exercise price
- $2.02
- Footnotes
- F2
ZPTA
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 68,558
- Exercise price
- $3.80
- Footnotes
- F3
ZPTA
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- Footnotes
- F4
ZPTA
holding
Derivative
Convertible Promissory Note
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500,000
- Exercise price
- $0.0400
- Footnotes
- F5
ZPTA
holding
Derivative
Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250,000
- Exercise price
- $0.0400
- Footnotes
- F5
ZPTA
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000,000
- Exercise price
- $0.0800
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
32,500,000 of the shares of restricted stock vest in equal monthly installments over a two-year period.
Footnote F2
100% of the shares subject to the option are fully vested and exercisable.
Footnote F3
The stock options are fully vested and exercisable.
Footnote F4
Restricted stock units convert into shares of common stock on a one-for-one basis. The restricted stock units will vest in three equal installments, with 25,000 shares of common stock vesting on October 10, 2024, 25,000 shares of common stock vesting on January 10, 2025, and 25,000 shares vesting on the date of the 2025 annual meeting of the Issuer's stockholders.
Footnote F5
The Reporting Person purchased a convertible promissory note in the principal amount of $100,000 and an accompanying five-year warrant to purchase 1,250,000 shares of common stock, for a total purchase price of $100,000. The conversion price of the note and exercise price of the warrant are each $0.04 per share.
Footnote F6
The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest in equal monthly increments over two years, with the first vesting date to occur on November 9, 2025, subject to continued service as a director of the Issuer on each applicable vesting date and the execution of the Issuer's Stock Option Agreement.
SEC remarks
The original Form 3 was filed at a time when the Issuer was subject to Section 12(b) of the Securities Exchange Act of 1934. That registration was subsequently withdrawn. The Issuer became subject to the reporting requirements under Section 12(g) of the Securities Exchange Act of 1934 on May 1, 2026. The Form 3 is now being amended to comply with the reporting requirements under Section 12(g).